Loading clinical trials...
Loading clinical trials...
Single-Blind, Randomized, Comparative, Phase I Study to Evaluate the Tolerability, Safety, and Pharmacokinetic Characteristics of Human Chorionic Gonadotropin Between Two Recombinant hCG Products, DA-3803 Injection and Ovidrel Liquid Injection, in Healthy Subjects
Conditions
Interventions
T-R (Test-Reference drug)
R-T (Reference-Test drug)
Start Date
May 1, 2010
Primary Completion Date
August 1, 2010
Completion Date
April 1, 2011
Last Updated
May 16, 2013
NCT06826365
NCT07153367
NCT07462065
NCT04872660
NCT05903859
NCT06742437
Lead Sponsor
Dong-A Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions